Want to join the conversation?
$ENDP 2Q15 Call: Our US generics business continues to deliver impressive results in the second quarter with sales of $338MM,& that contributed YTD growth of 44% versus prior year. Our YTD 2015 results primarily benefit from organic growth & number of value-creating acquisitions as well as LIDODERM AG, which was a strong source of growth as well.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.